SCHEMBL723314

SCHEMBL723314

Cc1ccc(OC2CCCCO2)c(I)c1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 2/20 0.39
SYK P43405 1/20 0.39
RAB9A P51151 3/20 0.35
MAPT P10636 1/20 0.35
ALDH1A1 P00352 1/20 0.35
TSHR P16473 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PTPN1 P18031 4/20 0.34
NPC1 O15118 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DHFR P00374 1/20 0.32
KDM4C Q9H3R0 1/20 0.32
TP53 P04637 1/20 0.32
CASP1 P29466 1/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.32
HSD11B1 P28845 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7772772 0.85 RAB9A (0.44) PDE4BSYKRAB9AMAPTALDH1A1
SCHEMBL818901 0.85 RAB9A (0.44) PDE4BSYKRAB9AMAPTALDH1A1
SCHEMBL22320334 0.84 PDE4B (0.40) PDE4BSYKRAB9AMAPTALDH1A1
SCHEMBL25738033 0.83 NPC1 (0.45) PDE4BRAB9AMAPTALDH1A1PTPN1
SCHEMBL23906802 0.82 PTPN1 (0.35) PDE4BRAB9APTPN1NPC1DHFR
SCHEMBL7772633 0.82 ACHE (0.49) PDE4BSYKRAB9AALDH1A1TSHR
SCHEMBL28630514 0.82 PDE4B (0.39) PDE4BSYKRAB9AMAPTALDH1A1
SCHEMBL7235885 0.82 ACHE (0.49) PDE4BSYKRAB9AALDH1A1TSHR
SCHEMBL18362187 0.82 ALDH1A1 (0.45) PDE4BSYKRAB9AMAPTALDH1A1
SCHEMBL1423552 0.82 PTPN1 (0.39) PDE4BSYKRAB9AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12637524-B2 Polymerization catalyst having a tetradentate ligand NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2026-05-26 US disclosed
US-20260071014-A1 GROUP III-HALIDE OR LANTHANIDE-HALIDE BIS(PHENYLPHENOXY) METAL-LIGAND COMPLEXES DOW GLOBAL TECHNOLOGIES LLC (US) 2026-03-12 US disclosed
EP-4565627-A1 GROUP III-HALIDE OR LANTHANIDE-HALIDE BIS(PHENYLPHENOXY) METAL-LIGAND COMPLEXES Dow Global Technologies LLC (US) 2025-06-11 EP disclosed
CN-119698441-A Group III-halide or lanthanide-halide bis (phenylphenoxy) metal-ligand complexes 陶氏环球技术有限责任公司 2025-03-25 CN disclosed
EP-4126995-B1 POLYMERIZATION CATALYST HAVING A TETRADENTATE LIGAND NOVA CHEM INT SA (CH) 2024-09-11 EP disclosed
WO-2024050359-A1 GROUP III-HALIDE OR LANTHANIDE-HALIDE BIS(PHENYLPHENOXY) METAL−LIGAND COMPLEXES DOW GLOBAL TECHNOLOGIES LLC (US) 2024-03-07 WO disclosed
WO-2024050359-A1 GROUP III-HALIDE OR LANTHANIDE-HALIDE BIS(PHENYLPHENOXY) METAL−LIGAND COMPLEXES DOW GLOBAL TECHNOLOGIES LLC (US) 2024-03-07 WO disclosed
US-20230148294-A1 POLYMERIZATION CATALYST HAVING A TETRADENTATE LIGAND NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2023-05-11 US disclosed
US-20230148294-A1 POLYMERIZATION CATALYST HAVING A TETRADENTATE LIGAND NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2023-05-11 US disclosed
US-20230148294-A1 POLYMERIZATION CATALYST HAVING A TETRADENTATE LIGAND NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2023-05-11 US disclosed
WO-2016003878-A1 CATALYST SYSTEMS FOR OLEFIN POLYMERIZATION DOW GLOBAL TECHNOLOGIES LLC (US) 2016-01-07 WO disclosed
US-9029487-B2 Process for polymerizing a polymerizable olefin and catalyst therefor DOW GLOBAL TECHNOLOGIES LLC (US) 2015-05-12 US disclosed
US-9029487-B2 Process for polymerizing a polymerizable olefin and catalyst therefor DOW GLOBAL TECHNOLOGIES LLC (US) 2015-05-12 US disclosed
US-9029487-B2 Process for polymerizing a polymerizable olefin and catalyst therefor DOW GLOBAL TECHNOLOGIES LLC (US) 2015-05-12 US disclosed
EP-2609123-A1 PROCESS FOR POLYMERIZING A POLYMERIZABLE OLEFIN AND CATALYST THEREFOR Dow Global Technologies LLC (US) 2013-07-03 EP disclosed
US-20130144018-A1 PROCESS FOR POLYMERIZING A POLYMERIZABLE OLEFIN AND CATALYST THEREFOR DOW GLOBAL TECHNOLOGIES LLC (US) 2013-06-06 US disclosed
US-20130144018-A1 PROCESS FOR POLYMERIZING A POLYMERIZABLE OLEFIN AND CATALYST THEREFOR DOW GLOBAL TECHNOLOGIES LLC (US) 2013-06-06 US disclosed
US-20130144018-A1 PROCESS FOR POLYMERIZING A POLYMERIZABLE OLEFIN AND CATALYST THEREFOR DOW GLOBAL TECHNOLOGIES LLC (US) 2013-06-06 US disclosed
WO-2012027448-A1 PROCESS FOR POLYMERIZING A POLYMERIZABLE OLEFIN AND CATALYST THEREFOR DOW GLOBAL TECHNOLOGIES LLC (US) 2012-03-01 WO disclosed
WO-2012027448-A1 PROCESS FOR POLYMERIZING A POLYMERIZABLE OLEFIN AND CATALYST THEREFOR DOW GLOBAL TECHNOLOGIES LLC (US) 2012-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071014-A1 GROUP III-HALIDE OR LANTHANIDE-HALIDE BIS(PHENYLPHENOXY) METAL-LIGAND COMPLEXES CCRL2, SCO2, BCL9L PDE4B 4873/4885SYK 1407/4885RAB9A 1506/4885
US-12637524-B2 Polymerization catalyst having a tetradentate ligand HAO2, POF1B, DUOX2 PDE4B 4874/4885SYK 274/4885RAB9A 4695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.